Darisham

The Challenge

Securing Pharma Manufacturing Infrastructure

Darisham, a leading pharmaceutical manufacturer operating under strict GxP/GAMP5 regulatory requirements, faced critical challenges in achieving comprehensive security visibility and compliance alignment across both production and non-production data centre infrastructures. Legacy systems lacked integrated monitoring, creating blind spots in their security posture and audit readiness.

Our Solution

Comprehensive Security Assessment: Dravincon conducted full-scope Vulnerability Assessment and Penetration Testing (VAPT) across the entire pharma infrastructure to uncover real-world exploitable weaknesses and validate compliance controls.

Integrated Security Operations Stack: We deployed a layered, enterprise-grade security operations platform encompassing SIEM (Security Information & Event Management), SOAR (Security Orchestration, Automation and Response), Security Incident Management, Asset Management, NMS (Network Monitoring Solution), and ITSM (IT Incident Management). This foundation enabled centralised monitoring and faster incident response.

Platform Hardening & Compliance: We strengthened core systems through Windows OS upgrades, File Integrity Monitoring (FIM) implementation, and infrastructure hardening using CIS Controls frameworks—all aligned with GxP and GAMP5 requirements.

The Results

Darisham achieved a transformative security and compliance outcome. The implementation delivered centralised monitoring with real-time visibility into security events, accelerated incident response capabilities, and robust platform hardening across the data centre. Most critically, the client gained structured risk governance, mapped technical and process controls toward GxP/GAMP5 compliance, and achieved complete audit readiness—positioning them as industry leaders in regulated environment security maturity.